|
Executive Summary
Drug Delivery Market
Dynamics
Technology and
Patient-Friendly Therapeutics
The Impact of
Self-Administration
Market Drivers and Risk
Factors
Competitive Landscape
I. Injectable Drug
Delivery
Injectable Drug Delivery
Sector Overview
Caregiver Preferences and
Expectations
Growth Factors
The Growth of
Self-Administration for Chronic Conditions
Managed Care Trends
End-User
Preferences and Expectations
Recombinant Proteins
and Antibody Drugs
Injectable Drug Delivery
Segment Analysis
Traditional Syringes
Supply Chain Overview
Technology Leaders
Key Buyer/End User
Factors
Historical Market Data
Traditional Syringe
Company Profiles
Safety Syringes
Factors Driving Safety
Syringe Growth
Safety Syringe Device
Design Analysis
Auto disable
Manual Disable
Auto and Manual
Retractable
The Leaders – Safety
Syringe Company Profiles
Needle-free Injectors
Disposable vs. Reusable
Prefilled vs vials
The Leaders –
Needle-free Company Profiles
Pen Injectors
Reusable Pens
Disposable Pens
Multifunction
Autoinjectors
The Leaders – Pen
Injector Company Profiles
Injectable Drug Delivery
Market Factors
Regulatory Factors
Technology Factors
Formulation
Factors
Geographic Factors
Assessment of Important
Self-Administration Therapeutics Segments
Arthritis
Cancer
Diabetes
Hepatitis
Human Growth Hormone
Multiple Sclerosis
Vaccines
II. Inhaled Drug Delivery
Inhaled Drug Delivery
Sector Overview
The Upper Respiratory
Market
The Systemic/Deep Lung
Market
Established Therapeutic
Targets
Emerging Therapies
Competing Technologies
Inhalation Technology
Product Design Factors
Inhaler Designs
Dry Powder Inhalers
Powder Technology
Packaging Issues
DPI Device Company
Profiles
Metered Dose Inhalers
Basic Designs
Breathe Actuated
Designs
MDI Device Company
Profiles
Nebulizers
Nebulizer Device
Company Profiles
Performance Factors
Bioavailability
Dose Reproducibility
Active Compound
Stability
Commercial Devices
Development-Stage Devices
Inhaled Drug Delivery
Therapeutic Segment Analysis
Allergic Rhinitis
Asthma
Cancer
Chronic Obstructive
Pulmonary Disease
Cystic Fibrosis
Diabetes
Hemophilia
Hereditary Diseases
Hormone Therapy/Replacement
Immune System Modulators
Multiple Sclerosis
Neurology
Osteoporosis
Pain Management
Sexual Health
Inhaled Drug Delivery
Market Factors
FDA Regulations
Device Packaging
Design Partnerships
III. Transdermal Drug
Delivery
Prescription Patch Market
Dynamics
Traditional Patch Markets
Recent and Emerging Markets
Transdermal Patch Market
Drivers
Prescription Patch Design &
Technology
Passive Patch Architecture
Passive Transdermal Patch
Design
Passive Patch Construction
Active Transport Patch
Technologies
Electrical Current
Iontophoresis
Electroporation
Microporation
Laser Ablation
Mechanical Arrays
Radio Frequency
Thermal/Heat
Ultrasound
Prescription Patch
Development Factors
The Design Cycle
Skin Patch Economics
Patch Manufacturing
Dynamics
Patch Manufacturing Company
Profiles
Patch Product Company
Profiles
FDA-Approved Patch
Therapies – Analysis and Market Data
ADHD
Contraception
Cardiovascular/Angina
Depression
Hormone Replacement Therapy
Hypertension
Local Anesthetics
Motion Sickness
Osteoporosis
Pain Management
Emerging Patch Therapeutics
– Opportunity and Risk Assessment
Alzheimer’s
Asthma
Diabetes
Parkinson’s Disease
Sexual Dysfunction
Vaccines
Transdermal Patch Market
Factors
FDA Regulations
Rx-to-OTC Switching
New Patch Technologies
Skin Patch Revenue Models
|